Skip to Content
You are currently on the new version of our website. Access the old version .

4,498 Results Found

  • Review
  • Open Access
6 Citations
4,486 Views
21 Pages

19 April 2024

Although lineage reprogramming from one cell type to another is becoming a breakthrough technology for cell-based therapy, several limitations remain to be overcome, including the low conversion efficiency and subtype specificity. To address these, m...

  • Article
  • Open Access
6 Citations
4,467 Views
22 Pages

Yamanaka reprogramming is revolutionary but inefficient, slow, and stochastic. The underlying molecular events for these mixed outcomes of induction of pluripotent stem cells (iPSC) reprogramming is still unclear. Previous studies about transcription...

  • Article
  • Open Access
10 Citations
3,664 Views
25 Pages

15 November 2020

Induction of pluripotent stem cells (iPSC) by OCT4 (octamer-binding transcription factor 4), SOX2 (SR box 2), KLF4 (Krüppel-Like Factor 4), and MYC (cellular Myelocytomatosis, c-MYC or MYC) (collectively OSKM) is revolutionary, but very ineffici...

  • Review
  • Open Access
3 Citations
3,979 Views
14 Pages

20 July 2024

Neuronal reprogramming is a promising approach for making major advancement in regenerative medicine. Distinct from the approach of induced pluripotent stem cells, neuronal reprogramming converts non-neuronal cells to neurons without going through a...

  • Review
  • Open Access
10 Citations
5,069 Views
9 Pages

Antioxidant Regulation of Cell Reprogramming

  • Yuichiro J. Suzuki and
  • Nataliia V. Shults

20 August 2019

Discovery of induced pluripotent stem cells (iPSCs) has revolutionized regeneration biology, providing further mechanistic insights and possible therapeutic applications. The original discovery by Yamanaka and co-workers showed that the expression of...

  • Review
  • Open Access
25 Citations
7,852 Views
14 Pages

MicroRNA Roles in Cell Reprogramming Mechanisms

  • Emilia Pascale,
  • Carmen Caiazza,
  • Martina Paladino,
  • Silvia Parisi,
  • Fabiana Passaro and
  • Massimiliano Caiazzo

10 March 2022

Cell reprogramming is a groundbreaking technology that, in few decades, generated a new paradigm in biomedical science. To date we can use cell reprogramming to potentially generate every cell type by converting somatic cells and suitably modulating...

  • Review
  • Open Access
28 Citations
6,519 Views
24 Pages

MYCN and Metabolic Reprogramming in Neuroblastoma

  • Mohit Bansal,
  • Anamika Gupta and
  • Han-Fei Ding

25 August 2022

Neuroblastoma is a pediatric cancer responsible for approximately 15% of all childhood cancer deaths. Aberrant MYCN activation, as a result of genomic MYCN amplification, is a major driver of high-risk neuroblastoma, which has an overall survival rat...

  • Review
  • Open Access
9 Citations
4,973 Views
17 Pages

Neuronal Reprogramming for Tissue Repair and Neuroregeneration

  • Roxanne Hsiang-Chi Liou,
  • Thomas L. Edwards,
  • Keith R. Martin and
  • Raymond Ching-Bong Wong

Stem cell and cell reprogramming technology represent a rapidly growing field in regenerative medicine. A number of novel neural reprogramming methods have been established, using pluripotent stem cells (PSCs) or direct reprogramming, to efficiently...

  • Review
  • Open Access
24 Citations
5,362 Views
21 Pages

YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming

  • Giorgia Di Benedetto,
  • Silvia Parisi,
  • Tommaso Russo and
  • Fabiana Passaro

Cell reprogramming can either refer to a direct conversion of a specialized cell into another or to a reversal of a somatic cell into an induced pluripotent stem cell (iPSC). It implies a peculiar modification of the epigenetic asset and gene regulat...

  • Review
  • Open Access
4 Citations
7,709 Views
14 Pages

Reprogramming Cells for Brain Repair

  • Alyx T. Guarino and
  • Randall D. McKinnon

6 August 2013

At present there are no clinical therapies that can repair traumatic brain injury, spinal cord injury or degenerative brain disease. While redundancy and rewiring of surviving circuits can recover some lost function, the brain and spinal column lack...

  • Review
  • Open Access
142 Citations
12,338 Views
14 Pages

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma

  • Hayato Nakagawa,
  • Yuki Hayata,
  • Satoshi Kawamura,
  • Tomoharu Yamada,
  • Naoto Fujiwara and
  • Kazuhiko Koike

15 November 2018

Metabolic reprogramming for adaptation to the local environment has been recognized as a hallmark of cancer. Although alterations in fatty acid (FA) metabolism in cancer cells have received less attention compared to other metabolic alterations such...

  • Review
  • Open Access
15 Citations
5,043 Views
19 Pages

Endothelial Reprogramming in Atherosclerosis

  • Lu Zhang,
  • Xin Wu and
  • Liang Hong

Atherosclerosis (AS) is a severe vascular disease that results in millions of cases of mortality each year. The development of atherosclerosis is associated with vascular structural lesions, characterized by the accumulation of immune cells, mesenchy...

  • Review
  • Open Access
12 Citations
6,446 Views
36 Pages

22 June 2021

Huntington’s disease (HD) is a neurodegenerative disorder characterized by the progressive decline of motor, cognitive, and psychiatric functions. HD results from an autosomal dominant mutation that causes a trinucleotide CAG repeat expansion and the...

  • Review
  • Open Access
55 Citations
9,220 Views
27 Pages

Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis

  • Charles N. S. Allen,
  • Sterling P. Arjona,
  • Maryline Santerre and
  • Bassel E. Sawaya

14 March 2022

Metabolic reprogramming is a hallmark of cancer and has proven to be critical in viral infections. Metabolic reprogramming provides the cell with energy and biomass for large-scale biosynthesis. Based on studies of the cellular changes that contribut...

  • Review
  • Open Access
4 Citations
3,701 Views
21 Pages

Direct Cardiac Reprogramming in the Age of Computational Biology

  • Rachelle Ambroise,
  • Paige Takasugi,
  • Jiandong Liu and
  • Li Qian

Heart disease continues to be one of the most fatal conditions worldwide. This is in part due to the maladaptive remodeling process by which ischemic cardiac tissue is replaced with a fibrotic scar. Direct cardiac reprogramming presents a unique solu...

  • Communication
  • Open Access
19 Citations
4,358 Views
7 Pages

7 February 2021

The expression “metabolic reprogramming” has been encountered more and more in the literature since the mid-1990s. It seems to encompass several notions depending on the author, but the lack of a clear definition allows it to be used as a “catch-all”...

  • Article
  • Open Access
8 Citations
3,289 Views
26 Pages

MicroRNA-375 Is Induced during Astrocyte-to-Neuron Reprogramming and Promotes Survival of Reprogrammed Neurons when Overexpressed

  • Xuanyu Chen,
  • Ivan Sokirniy,
  • Xin Wang,
  • Mei Jiang,
  • Natalie Mseis-Jackson,
  • Christine Williams,
  • Kristopher Mayes,
  • Na Jiang,
  • Brendan Puls and
  • Hedong Li
  • + 2 authors

3 September 2023

While astrocyte-to-neuron (AtN) reprogramming holds great promise in regenerative medicine, the molecular mechanisms that govern this unique biological process remain elusive. To understand the function of miRNAs during the AtN reprogramming process,...

  • Article
  • Open Access
2,570 Views
31 Pages

An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers

  • Eleftheria Klagkou,
  • Dimitrios Valakos,
  • Spyros Foutadakis,
  • Alexander Polyzos,
  • Angeliki Papadopoulou,
  • Giannis Vatsellas and
  • Dimitris Thanos

6 December 2024

Cellular reprogramming of somatic cells towards induced pluripotency is a multistep stochastic process mediated by the transcription factors Oct4, Sox2, Klf4 and c-Myc (OSKM), which orchestrate global epigenetic and transcriptional changes. We perfor...

  • Review
  • Open Access
5 Citations
4,593 Views
12 Pages

25 November 2021

Direct reprogramming of fibroblasts into CM-like cells has emerged as an attractive strategy to generate induced CMs (iCMs) in heart regeneration. However, low conversion rate, poor purity, and the lack of precise conversion of iCMs are still present...

  • Review
  • Open Access
10 Citations
6,486 Views
28 Pages

Cell Reprogramming for Regeneration and Repair of the Nervous System

  • Isaac H. Clark,
  • Alex Roman,
  • Emily Fellows,
  • Swathi Radha,
  • Susanna R. Var,
  • Zachary Roushdy,
  • Samuel M. Borer,
  • Samantha Johnson,
  • Olivia Chen and
  • Andrew W. Grande
  • + 5 authors

A persistent barrier to the cure and treatment of neurological diseases is the limited ability of the central and peripheral nervous systems to undergo neuroregeneration and repair. Recent efforts have turned to regeneration of various cell types thr...

  • Review
  • Open Access
3 Citations
4,000 Views
27 Pages

Cell Reprogramming, Transdifferentiation, and Dedifferentiation Approaches for Heart Repair

  • Micael Almeida,
  • José M. Inácio,
  • Carlos M. Vital,
  • Madalena R. Rodrigues,
  • Beatriz C. Araújo and
  • José A. Belo

Cardiovascular disease (CVD) remains the leading cause of death globally, with myocardial infarction (MI) being a major contributor. The current therapeutic approaches are limited in effectively regenerating damaged cardiac tissue. Up-to-date strateg...

  • Review
  • Open Access
35 Citations
8,034 Views
13 Pages

Direct Cardiac Reprogramming: A Novel Approach for Heart Regeneration

  • Hidenori Tani,
  • Taketaro Sadahiro and
  • Masaki Ieda

5 September 2018

Cardiac diseases are among the most common causes of death globally. Cardiac muscle has limited proliferative capacity, and regenerative therapies are highly in demand as a new treatment strategy. Although pluripotent reprogramming has been developed...

  • Communication
  • Open Access
8 Citations
2,722 Views
9 Pages

Chamber-Specific Protein Expression during Direct Cardiac Reprogramming

  • Zhentao Zhang,
  • Jesse Villalpando,
  • Wenhui Zhang and
  • Young-Jae Nam

16 June 2021

Forced expression of core cardiogenic transcription factors can directly reprogram fibroblasts to induced cardiomyocyte-like cells (iCMs) in vitro and in vivo. This cardiac reprogramming approach provides a proof of concept for induced heart regenera...

  • Review
  • Open Access
13 Citations
3,784 Views
13 Pages

T-Cell Metabolic Reprogramming in Atherosclerosis

  • Shuye Chang,
  • Zhaohui Wang and
  • Tianhui An

Atherosclerosis is a key pathological basis for cardiovascular diseases, significantly influenced by T-cell-mediated immune responses. T-cells differentiate into various subtypes, such as pro-inflammatory Th1/Th17 and anti-inflammatory Th2/Treg cells...

  • Article
  • Open Access
8 Citations
4,802 Views
22 Pages

Transcriptome Profiling of Embryonic Retinal Pigment Epithelium Reprogramming

  • Jared A. Tangeman,
  • Agustín Luz-Madrigal,
  • Sutharzan Sreeskandarajan,
  • Erika Grajales-Esquivel,
  • Lin Liu,
  • Chun Liang,
  • Panagiotis A. Tsonis and
  • Katia Del Rio-Tsonis

29 May 2021

The plasticity of human retinal pigment epithelium (RPE) has been observed during proliferative vitreoretinopathy, a defective repair process during which injured RPE gives rise to fibrosis. In contrast, following injury, the RPE of the embryonic chi...

  • Review
  • Open Access
269 Citations
21,136 Views
22 Pages

Metabolic Reprogramming in Chloroplasts under Heat Stress in Plants

  • Qing-Long Wang,
  • Juan-Hua Chen,
  • Ning-Yu He and
  • Fang-Qing Guo

Increases in ambient temperatures have been a severe threat to crop production in many countries around the world under climate change. Chloroplasts serve as metabolic centers and play a key role in physiological adaptive processes to heat stress. In...

  • Review
  • Open Access
168 Citations
13,906 Views
23 Pages

2 January 2021

Cancer cells face various metabolic challenges during tumor progression, including growth in the nutrient-altered and oxygen-deficient microenvironment of the primary site, intravasation into vessels where anchorage-independent growth is required, an...

  • Article
  • Open Access
4 Citations
2,653 Views
10 Pages

Influence of Cell Type in In Vitro Induced Reprogramming in Cattle

  • Kaiana Recchia,
  • Laís Vicari de Figueiredo Pessôa,
  • Naira Caroline Godoy Pieri,
  • Pedro Ratto Lisboa Pires and
  • Fabiana Fernandes Bressan

28 July 2022

Induced pluripotent stem cells (iPSCs) have been considered an essential tool in stem cell research due to their potential to develop new therapies and technologies and answer essential questions about mammalian early development. An important step i...

  • Review
  • Open Access
14 Citations
7,537 Views
25 Pages

RNA-Based Strategies for Cell Reprogramming toward Pluripotency

  • Anaëlle Bailly,
  • Ollivier Milhavet and
  • Jean-Marc Lemaitre

Cell therapy approaches to treat a wide range of pathologies have greatly benefited from cell reprogramming techniques that allow the conversion of a somatic cell into a pluripotent cell. Many technological developments have been made since the initi...

  • Article
  • Open Access
20 Citations
4,585 Views
15 Pages

Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma

  • Qingqing Wang,
  • Yexiong Tan,
  • Tianyi Jiang,
  • Xiaolin Wang,
  • Qi Li,
  • Yanli Li,
  • Liwei Dong,
  • Xinyu Liu and
  • Guowang Xu

22 March 2022

Hepatocarcinogenesis is frequently accompanied by substantial metabolic reprogramming to maximize the growth and proliferation of cancer cells. In this study, we carried out a comprehensive study of metabolomics and lipidomics profiles combined with...

  • Review
  • Open Access
14 Citations
5,656 Views
13 Pages

Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer

  • Pei-Yi Chu,
  • Ming-Feng Hou,
  • Ji-Ching Lai,
  • Long-Fong Chen and
  • Chang-Shen Lin

Breast cancer is the most common malignancy in women worldwide and can be categorized into several subtypes according to histopathological parameters or genomic signatures. Such heterogeneity of breast cancer can arise from the reactivation of mammar...

  • Review
  • Open Access
48 Citations
15,881 Views
13 Pages

The ability to generate transplantable neural cells in a large quantity in the laboratory is a critical step in the field of developing stem cell regenerative medicine for neural repair. During the last few years, groundbreaking studies have shown t...

  • Review
  • Open Access
11 Citations
3,977 Views
14 Pages

Epigenomic Reprogramming in Gout

  • Ancuta R. Straton,
  • Brenda Kischkel,
  • Tania O. Crișan and
  • Leo A. B. Joosten

Gout is a crystal-induced arthropathy in which monosodium urate (MSU) crystals precipitate within joints as a result of persistent hyperuricemia and elicit an inflammatory response. An intriguing aspect is the occurrence of gout in only 10–15% of hyp...

  • Review
  • Open Access
6 Citations
3,463 Views
23 Pages

Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis

  • Yi-Fang Yang,
  • Chien-Hsiu Li,
  • Huei-Yu Cai,
  • Bo-Syuan Lin,
  • Cheorl-Ho Kim and
  • Yu-Chan Chang

13 December 2022

Cellular metabolism governs the signaling that supports physiological mechanisms and homeostasis in an individual, including neuronal transmission, wound healing, and circadian clock manipulation. Various factors have been linked to abnormal metaboli...

  • Review
  • Open Access
55 Citations
9,649 Views
18 Pages

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

  • Jing Wang,
  • Yuanli He,
  • Feiming Hu,
  • Chenchen Hu,
  • Yuanjie Sun,
  • Kun Yang and
  • Shuya Yang

14 November 2024

Metabolic reprogramming of immune cells within the tumor microenvironment (TME) plays a pivotal role in shaping tumor progression and responses to therapy. The intricate interplay between tumor cells and immune cells within this ecosystem influences...

  • Review
  • Open Access
25 Citations
5,841 Views
16 Pages

4 July 2019

Coronary artery disease is the most common form of cardiovascular diseases, resulting in the loss of cardiomyocytes (CM) at the site of ischemic injury. To compensate for the loss of CMs, cardiac fibroblasts quickly respond to injury and initiate car...

  • Review
  • Open Access
6 Citations
9,777 Views
26 Pages

Looking into the Black Box: Insights into the Mechanisms of Somatic Cell Reprogramming

  • Laurent David,
  • Payman Samavarchi-Tehrani,
  • Azadeh Golipour and
  • Jeffrey L. Wrana

13 January 2011

The dramatic discovery that somatic cells could be reprogrammed to induced pluripotent stem cells (iPSCs), by the expression of just four factors, has opened new opportunities for regenerative medicine and novel ways of modeling human diseases. Exten...

  • Review
  • Open Access
23 Citations
9,811 Views
26 Pages

Direct Reprogramming—The Future of Cardiac Regeneration?

  • Stefanie A. Doppler,
  • Marcus-André Deutsch,
  • Rüdiger Lange and
  • Markus Krane

29 July 2015

Today, the only available curative therapy for end stage congestive heart failure (CHF) is heart transplantation. This therapeutic option is strongly limited by declining numbers of available donor hearts and by restricted long-term performance of th...

  • Review
  • Open Access
10 Citations
5,419 Views
21 Pages

Direct Reprogramming of Cardiac Fibroblasts to Repair the Injured Heart

  • Emma Adams,
  • Rachel McCloy,
  • Ashley Jordan,
  • Kaitlin Falconer and
  • Iain M. Dykes

Coronary heart disease is a leading cause of mortality and morbidity. Those that survive acute myocardial infarction are at significant risk of subsequent heart failure due to fibrotic remodelling of the infarcted myocardium. By applying knowledge fr...

  • Review
  • Open Access
12 Citations
5,627 Views
20 Pages

Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair

  • Xingyu He,
  • Jialiang Liang,
  • Christian Paul,
  • Wei Huang,
  • Suchandrima Dutta and
  • Yigang Wang

3 December 2022

Continuous loss of cardiomyocytes (CMs) is one of the fundamental characteristics of many heart diseases, which eventually can lead to heart failure. Due to the limited proliferation ability of human adult CMs, treatment efficacy has been limited in...

  • Article
  • Open Access
8 Citations
3,540 Views
20 Pages

Direct Cardiac Epigenetic Reprogramming through Codelivery of 5′Azacytidine and miR-133a Nanoformulation

  • Priyadharshni Muniyandi,
  • Vivekanandan Palaninathan,
  • Tatsuro Hanajiri and
  • Toru Maekawa

2 December 2022

Direct reprogramming of cardiac fibroblasts to induced cardiomyocytes (iCMs) is a promising approach to cardiac regeneration. However, the low yield of reprogrammed cells and the underlying epigenetic barriers limit its potential. Epigenetic control...

  • Review
  • Open Access
15 Citations
6,682 Views
30 Pages

The Future of Direct Cardiac Reprogramming: Any GMT Cocktail Variety?

  • Leyre López-Muneta,
  • Josu Miranda-Arrubla and
  • Xonia Carvajal-Vergara

26 October 2020

Direct cardiac reprogramming has emerged as a novel therapeutic approach to treat and regenerate injured hearts through the direct conversion of fibroblasts into cardiac cells. Most studies have focused on the reprogramming of fibroblasts into induce...

  • Review
  • Open Access
20 Citations
6,433 Views
18 Pages

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy

  • Liang Yan,
  • Yanlian Tan,
  • Guo Chen,
  • Jun Fan and
  • Jun Zhang

24 September 2021

Immune escape is one of the hallmarks of cancer. While metabolic reprogramming provides survival advantage to tumor cancer cells, accumulating data also suggest such metabolic rewiring directly affects the activation, differentiation and function of...

  • Review
  • Open Access
11 Citations
5,901 Views
22 Pages

Insights into Metabolic Reprogramming in Tumor Evolution and Therapy

  • Ching-Feng Chiu,
  • Jonathan Jaime G. Guerrero,
  • Ric Ryan H. Regalado,
  • Jiayan Zhou,
  • Kin Israel Notarte,
  • Yu-Wei Lu,
  • Paolo C. Encarnacion,
  • Cidne Danielle D. Carles,
  • Edrian M. Octavo and
  • Shih-Yi Huang
  • + 2 authors

17 October 2024

Background: Cancer remains a global health challenge, characterized not just by uncontrolled cell proliferation but also by the complex metabolic reprogramming that underlies its development and progression. Objectives: This review delves into the in...

  • Article
  • Open Access
3 Citations
3,247 Views
25 Pages

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency

  • Nikolaos Bekas,
  • Martina Samiotaki,
  • Maria Papathanasiou,
  • Panagiotis Mokos,
  • Athanasios Pseftogas,
  • Konstantinos Xanthopoulos,
  • Dimitris Thanos,
  • George Mosialos and
  • Dimitra Dafou

15 October 2023

CYLD is a tumor suppressor gene coding for a deubiquitinating enzyme that has a critical regulatory function in a variety of signaling pathways and biological processes involved in cancer development and progression, many of which are also key modula...

  • Review
  • Open Access
407 Views
27 Pages

Oncofetal reprogramming has recently emerged as a critical concept in translational cancer research, particularly for its role in driving therapeutic resistance across a variety of malignancies. This biological process refers to a pattern of gene exp...

  • Review
  • Open Access
26 Citations
9,904 Views
22 Pages

Metabolic Reprogramming in Cancer: Role of HPV 16 Variants

  • Adán Arizmendi-Izazaga,
  • Napoleón Navarro-Tito,
  • Hilda Jiménez-Wences,
  • Miguel A. Mendoza-Catalán,
  • Dinorah N. Martínez-Carrillo,
  • Ana E. Zacapala-Gómez,
  • Monserrat Olea-Flores,
  • Roberto Dircio-Maldonado,
  • Francisco I. Torres-Rojas and
  • Julio Ortiz-Ortiz
  • + 2 authors

Metabolic reprogramming is considered one of the hallmarks in cancer and is characterized by increased glycolysis and lactate production, even in the presence of oxygen, which leads the cancer cells to a process called “aerobic glycolysis” or “Warbur...

  • Feature Paper
  • Review
  • Open Access
22 Citations
4,884 Views
15 Pages

Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor

  • Izadora Lorrany Alves Rabelo,
  • Vanessa Fernandes Arnaud-Sampaio,
  • Elena Adinolfi,
  • Henning Ulrich and
  • Claudiana Lameu

14 July 2021

The heterogeneity of tumor cell mass and the plasticity of cancer cell phenotypes in solid tumors allow for the insurgence of resistant and metastatic cells, responsible for cancer patients’ clinical management’s main challenges. Among several factor...

  • Review
  • Open Access
42 Citations
6,814 Views
25 Pages

Linking Metabolic Reprogramming, Plasticity and Tumor Progression

  • Oleg Shuvalov,
  • Alexandra Daks,
  • Olga Fedorova,
  • Alexey Petukhov and
  • Nickolai Barlev

12 February 2021

The specific molecular features of cancer cells that distinguish them from the normal ones are denoted as “hallmarks of cancer”. One of the critical hallmarks of cancer is an altered metabolism which provides tumor cells with energy and structural re...

  • Review
  • Open Access
6 Citations
7,637 Views
17 Pages

In Vivo Reprogramming Using Yamanaka Factors in the CNS: A Scoping Review

  • Han Eol Cho,
  • Siwoo Lee,
  • Jung Hwa Seo,
  • Seong-Woong Kang,
  • Won Ah Choi and
  • Sung-Rae Cho

15 February 2024

Central nervous system diseases, particularly neurodegenerative disorders, pose significant challenges in medicine. These conditions, characterized by progressive neuronal loss, have remained largely incurable, exacting a heavy toll on individuals an...

of 90